AC019206.1 | | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images/40470/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40470/87248_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins Predicted intracellular proteins
| | ![](/images/34510/if_selected_60x60.jpg) | | ![](/images/9796/24747_B_1_7_rna_selected_60x60.jpg) | Group enriched |
AICDA | Activation-induced cytidine deaminase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ANKRD18A | Ankyrin repeat domain 18A | Predicted intracellular proteins
| ![](/images/46346/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46346/122956_A_5_8_rna_selected_60x60.jpg) | Group enriched |
ANKRD55 | Ankyrin repeat domain 55 | Predicted intracellular proteins
| ![](/images/51049/118126_A_7_8_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51049/118128_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ANKRD61 | Ankyrin repeat domain 61 | Predicted intracellular proteins
| ![](/images/29511/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29511/60784_B_7_8_rna_selected_60x60.jpg) | Group enriched |
ATP1A4 | ATPase, Na+/K+ transporting, alpha 4 polypeptide | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37002/84229_B_8_4_rna_selected_60x60.jpg) | Group enriched |
BLK | BLK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images/5093/14004_A_6_8_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5093/14003_B_8_2_rna_selected_60x60.jpg) | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/47211/120711_A_1_7_selected_60x60.jpg) | ![](/images/62029/148777_A_5_6_rna_selected_60x60.jpg) | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes Predicted intracellular proteins
| ![](/images/62836/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62836/140376_A_3_1_rna_selected_60x60.jpg) | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/40937/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40937/90878_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/6839/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6839/16257_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CD177 | CD177 molecule | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16110/36118_A_9_1_rna_selected_60x60.jpg) | Group enriched |
CD72 | CD72 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/44658/143095_A_8_6_selected_60x60.jpg) | ![](/images/2505/6522_A_7_1_rna_selected_60x60.jpg) | Group enriched |
CEACAM4 | Carcinoembryonic antigen-related cell adhesion molecule 4 | Predicted membrane proteins
| ![](/images/12801/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12801/30283_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11041/27138_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CHD2 | Chromodomain helicase DNA binding protein 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/10575/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10575/25814_A_2_7_rna_selected_60x60.jpg) | Group enriched |
CHODL | Chondrolectin | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/17282/156829_A_5_6_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17282/156826_B_8_7_rna_selected_60x60.jpg) | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/21771/ihc_selected_60x60.jpg) | ![](/images/21771/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21771/48557_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CHST13 | Carbohydrate (chondroitin 4) sulfotransferase 13 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CLEC17A | C-type lectin domain family 17, member A | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/4906/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4906/19765_B_7_4_rna_selected_60x60.jpg) | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/14044/if_selected_60x60.jpg) | ![](/images/14044/ihc_cell_selected_60x60.jpg) | ![](/images/3789/10114_B_2_1_rna_selected_60x60.jpg) | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33689/80801_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CLEC5A | C-type lectin domain family 5, member A | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/9719/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9719/29978_B_3_7_rna_selected_60x60.jpg) | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/60715/145214_A_11_11_selected_60x60.jpg) | ![](/images/2659/6600_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CXCL13 | Chemokine (C-X-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| ![](/images/52613/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52613/126778_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CXCL9 | Chemokine (C-X-C motif) ligand 9 | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
DNAH10 | Dynein, axonemal, heavy chain 10 | Predicted intracellular proteins
| ![](/images/39066/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39066/83259_B_8_7_rna_selected_60x60.jpg) | Group enriched |
DPPA4 | Developmental pluripotency associated 4 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35250/124854_B_8_2_rna_selected_60x60.jpg) | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48930/ihc_cell_selected_60x60.jpg) | ![](/images/48930/118540_B_9_2_rna_selected_60x60.jpg) | Group enriched |
DTHD1 | Death domain containing 1 | Predicted intracellular proteins
| ![](/images/37761/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37761/77375_B_9_2_rna_selected_60x60.jpg) | Group enriched |
EN1 | Engrailed homeobox 1 | Predicted intracellular proteins Transcription factors
| ![](/images/14884/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14884/36655_B_7_3_rna_selected_60x60.jpg) | Group enriched |
FAM129C | Family with sequence similarity 129, member C | Predicted intracellular proteins
| ![](/images/43277/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43277/92336_B_7_8_rna_selected_60x60.jpg) | Group enriched |
FAM178B | Family with sequence similarity 178, member B | Predicted intracellular proteins
| ![](/images/42516/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42516/95232_B_9_2_rna_selected_60x60.jpg) | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1295/3239_A_3_3_rna_selected_60x60.jpg) | Group enriched |
FCRL2 | Fc receptor-like 2 | CD markers Predicted membrane proteins
| ![](/images/17619/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17619/89010_B_8_6_rna_selected_60x60.jpg) | Group enriched |
FCRL3 | Fc receptor-like 3 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| ![](/images/15508/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15508/34676_B_9_2_rna_selected_60x60.jpg) | Group enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| ![](/images/54030/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54030/123242_B_7_8_rna_selected_60x60.jpg) | Group enriched |